Literature DB >> 26743213

The IL-33 gene is related to increased susceptibility to systemic sclerosis.

Suleyman Serdar Koca1, Yavuz Pehlivan2, Murat Kara3, Fatma Alibaz-Oner4, Serdar Oztuzcu5, Neslihan Yilmaz6, Gozde Yildirim Cetin7, Bunyamin Kisacik8, Metin Ozgen9, Omer Nuri Pamuk10, Haner Direskeneli4, Mehmet Sayarlioglu9, Ahmet Mesut Onat8.   

Abstract

Systemic sclerosis (SSc) is a chronic inflammatory disease characterized by widespread fibrosis of the skin and several visceral organs. The pro-fibrotic potential of interleukin (IL)-33 has been demonstrated by in both in vitro and in vivo settings; moreover, increased level of IL-33 has also been reported in patients with SSc. Therefore, the aim of the present study was to detect the potential association of IL-33 gene polymorphisms on the susceptibility of SSc. A total of 300 SSc patients and 280 healthy controls (HC) were enrolled in this multicentric preliminary candidate gene study. DNA samples were harvested using an appropriate commercial DNA isolation kit. Four single nucleotide polymorphisms (SNPs) of IL-33 gene (rs7044343, rs1157505, rs11792633 and rs1929992) were genotyped using the appropriate commercial primer/probe sets on real-time PCR. There was no significant difference in terms of the allelic distributions and minor allele frequencies of evaluated four IL-33 polymorphisms between the SSc and HC groups (P > 0.05 for all). Moreover, the genotypic distributions of rs1157505, rs11792633 and rs1929992 polymorphisms were not significantly different (P > 0.05 for all). However, CC genotype of rs7044343 SNP was significantly higher in the SSc group compared to the HC group (P = 0.013, OR 1.75, 95 % CI 1.12-2.72). This preliminary candidate gene study demonstrates that rs7044343 polymorphism of IL-33 gene is associated with the susceptibility to the SSc in Turkish population. It may be suggested that IL-33 gene may be a candidate gene to research in SSc.

Entities:  

Keywords:  Genetic; IL-33 gene polymorphism; Systemic sclerosis

Mesh:

Substances:

Year:  2016        PMID: 26743213     DOI: 10.1007/s00296-015-3417-8

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  35 in total

1.  IL-1 receptor accessory protein and ST2 comprise the IL-33 receptor complex.

Authors:  Alissa A Chackerian; Elizabeth R Oldham; Erin E Murphy; Jochen Schmitz; Stefan Pflanz; Robert A Kastelein
Journal:  J Immunol       Date:  2007-08-15       Impact factor: 5.422

2.  2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative.

Authors:  Frank van den Hoogen; Dinesh Khanna; Jaap Fransen; Sindhu R Johnson; Murray Baron; Alan Tyndall; Marco Matucci-Cerinic; Raymond P Naden; Thomas A Medsger; Patricia E Carreira; Gabriela Riemekasten; Philip J Clements; Christopher P Denton; Oliver Distler; Yannick Allanore; Daniel E Furst; Armando Gabrielli; Maureen D Mayes; Jacob M van Laar; James R Seibold; Laszlo Czirjak; Virginia D Steen; Murat Inanc; Otylia Kowal-Bielecka; Ulf Müller-Ladner; Gabriele Valentini; Douglas J Veale; Madelon C Vonk; Ulrich A Walker; Lorinda Chung; David H Collier; Mary Ellen Csuka; Barri J Fessler; Serena Guiducci; Ariane Herrick; Vivien M Hsu; Sergio Jimenez; Bashar Kahaleh; Peter A Merkel; Stanislav Sierakowski; Richard M Silver; Robert W Simms; John Varga; Janet E Pope
Journal:  Arthritis Rheum       Date:  2013-10-03

3.  Increased circulating levels of interleukin 33 in systemic sclerosis correlate with early disease stage and microvascular involvement.

Authors:  Mirko Manetti; Serena Guiducci; Claudia Ceccarelli; Eloisa Romano; Silvia Bellando-Randone; Maria Letizia Conforti; Lidia Ibba-Manneschi; Marco Matucci-Cerinic
Journal:  Ann Rheum Dis       Date:  2011-05-12       Impact factor: 19.103

4.  Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus.

Authors:  Timothy R D J Radstake; Olga Gorlova; Blanca Rueda; Jose-Ezequiel Martin; Behrooz Z Alizadeh; Rogelio Palomino-Morales; Marieke J Coenen; Madelon C Vonk; Alexandre E Voskuyl; Annemie J Schuerwegh; Jasper C Broen; Piet L C M van Riel; Ruben van 't Slot; Annet Italiaander; Roel A Ophoff; Gabriela Riemekasten; Nico Hunzelmann; Carmen P Simeon; Norberto Ortego-Centeno; Miguel A González-Gay; María F González-Escribano; Paolo Airo; Jaap van Laar; Ariane Herrick; Jane Worthington; Roger Hesselstrand; Vanessa Smith; Filip de Keyser; Fredric Houssiau; Meng May Chee; Rajan Madhok; Paul Shiels; Rene Westhovens; Alexander Kreuter; Hans Kiener; Elfride de Baere; Torsten Witte; Leonid Padykov; Lars Klareskog; Lorenzo Beretta; Rafaella Scorza; Benedicte A Lie; Anna-Maria Hoffmann-Vold; Patricia Carreira; John Varga; Monique Hinchcliff; Peter K Gregersen; Annette T Lee; Jun Ying; Younghun Han; Shih-Feng Weng; Christopher I Amos; Fredrick M Wigley; Laura Hummers; J Lee Nelson; Sandeep K Agarwal; Shervin Assassi; Pravitt Gourh; Filemon K Tan; Bobby P C Koeleman; Frank C Arnett; Javier Martin; Maureen D Mayes
Journal:  Nat Genet       Date:  2010-04-11       Impact factor: 38.330

5.  Familial occurrence frequencies and relative risks for systemic sclerosis (scleroderma) in three United States cohorts.

Authors:  F C Arnett; M Cho; S Chatterjee; M B Aguilar; J D Reveille; M D Mayes
Journal:  Arthritis Rheum       Date:  2001-06

6.  A disease severity scale for systemic sclerosis: development and testing.

Authors:  T A Medsger; A J Silman; V D Steen; C M Black; A Akesson; P A Bacon; C A Harris; S Jablonska; M I Jayson; S A Jimenez; T Krieg; E C Leroy; P J Maddison; M L Russell; R K Schachter; F A Wollheim; H Zacharaie
Journal:  J Rheumatol       Date:  1999-10       Impact factor: 4.666

7.  An interleukin-33 gene polymorphism is a modifier for eosinophilia in rats.

Authors:  H Luo; K Higuchi; K Matsumoto; M Mori
Journal:  Genes Immun       Date:  2013-02-28       Impact factor: 2.676

8.  Association of serum interleukin-33 level and the interleukin-33 genetic variant with Japanese cedar pollinosis.

Authors:  M Sakashita; T Yoshimoto; T Hirota; M Harada; K Okubo; Y Osawa; S Fujieda; Y Nakamura; K Yasuda; K Nakanishi; M Tamari
Journal:  Clin Exp Allergy       Date:  2008-12       Impact factor: 5.018

Review 9.  Fibrosis in connective tissue disease: the role of the myofibroblast and fibroblast-epithelial cell interactions.

Authors:  Thomas Krieg; David Abraham; Robert Lafyatis
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

10.  New Insights in the Immunobiology of IL-1 Family Members.

Authors:  Frank L van de Veerdonk; Mihai G Netea
Journal:  Front Immunol       Date:  2013-07-08       Impact factor: 7.561

View more
  16 in total

Review 1.  IL-33/ST2 Axis in Organ Fibrosis.

Authors:  Ourania S Kotsiou; Konstantinos I Gourgoulianis; Sotirios G Zarogiannis
Journal:  Front Immunol       Date:  2018-10-24       Impact factor: 7.561

2.  Association of interleukin-1 family cytokines single nucleotide polymorphisms with susceptibility to systemic sclerosis: an independent case-control study and a meta-analysis.

Authors:  Xiao-Lei Huang; Guo-Cui Wu; Yu-Jie Wang; Xiao-Ke Yang; Guo-Jun Yang; Jin-Hui Tao; Yu Duan; Jun-Wei Yan; Xiang-Pei Li; Dong-Qing Ye; Jing Wang
Journal:  Immunol Res       Date:  2016-08       Impact factor: 2.829

3.  Elevated serum levels of interleukin-1β and interleukin-33 in patients with systemic sclerosis in Chinese population.

Authors:  Y-J Zhang; Q Zhang; G-J Yang; J-H Tao; G-C Wu; X-L Huang; Y Duan; X-P Li; D-Q Ye; J Wang
Journal:  Z Rheumatol       Date:  2018-03       Impact factor: 1.372

4.  IL-33/Regulatory T-Cell Axis Suppresses Skin Fibrosis.

Authors:  Se Yun Cheon; Jong Ho Park; Amir H Ameri; Richard T Lee; Rosalynn M Nazarian; Shadmehr Demehri
Journal:  J Invest Dermatol       Date:  2022-03-25       Impact factor: 7.590

5.  Association of interleukin-33 gene polymorphisms with susceptibility to late onset Alzheimer's disease: a meta-analysis.

Authors:  Xin Zhong; Ming-Yan Liu; Miao He; Ke Du; Min-Jie Wei
Journal:  Neuropsychiatr Dis Treat       Date:  2017-08-30       Impact factor: 2.570

6.  The rs7044343 Polymorphism of the Interleukin 33 Gene Is Associated with Decreased Risk of Developing Premature Coronary Artery Disease and Central Obesity, and Could Be Involved in Regulating the Production of IL-33.

Authors:  Javier Angeles-Martínez; Rosalinda Posadas-Sánchez; Luis Llorente; Edith Alvarez-León; Julian Ramírez-Bello; Teresa Villarreal-Molina; Guadalupe Lima; Guillermo Cardoso-Saldaña; José Manuel Rodríguez-Pérez; Nonanzit Pérez-Hernández; José Manuel Fragoso; Carlos Posadas-Romero; Gilberto Vargas-Alarcón
Journal:  PLoS One       Date:  2017-01-03       Impact factor: 3.240

7.  Interleukin-33 Contributes Toward Loss of Tolerance by Promoting B-Cell-Activating Factor of the Tumor-Necrosis-Factor Family (BAFF)-Dependent Autoantibody Production.

Authors:  William A Rose; Angela J Okragly; Ningjie N Hu; Montanea R Daniels; Andrea P Martin; Yi Ting Koh; Kristine Kikly; Robert J Benschop
Journal:  Front Immunol       Date:  2018-12-06       Impact factor: 7.561

Review 8.  Interleukin-33 in Systemic Sclerosis: Expression and Pathogenesis.

Authors:  Liya Li; Honglin Zhu; Xiaoxia Zuo
Journal:  Front Immunol       Date:  2018-11-15       Impact factor: 7.561

9.  Interaction between IL-33 Gene Polymorphisms and Current Smoking with Susceptibility to Systemic Lupus Erythematosus.

Authors:  Xiaohua Zhu; Lin Xie; Haihong Qin; Jun Liang; Yongsheng Yang; Jinhua Xu; Tiejun Zhang
Journal:  J Immunol Res       Date:  2019-03-11       Impact factor: 4.818

10.  IL-33 Gene Polymorphisms as Potential Biomarkers of Disease Susceptibility and Response to TNF Inhibitors in Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis Patients.

Authors:  Milena Iwaszko; Joanna Wielińska; Jerzy Świerkot; Katarzyna Kolossa; Renata Sokolik; Bartosz Bugaj; Monika Chaszczewska-Markowska; Sławomir Jeka; Katarzyna Bogunia-Kubik
Journal:  Front Immunol       Date:  2021-06-11       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.